Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1984 4
1985 1
1987 1
1988 1
1989 1
1990 1
1991 3
1992 3
1993 1
1994 2
1995 1
1996 2
1999 2
2000 1
2001 1
2002 3
2003 1
2004 3
2005 3
2006 2
2007 3
2008 3
2009 3
2010 5
2011 3
2012 4
2013 3
2014 4
2015 2
2016 6
2017 5
2018 7
2019 1
2020 5
2021 3
2022 5
2023 0

Text availability

Article attribute

Article type

Publication date

Search Results

89 results

Results by year

Filters applied: . Clear all
Page 1
Hyperleukocytosis and leukostasis: management of a medical emergency.
Giammarco S, Chiusolo P, Piccirillo N, Di Giovanni A, Metafuni E, Laurenti L, Sica S, Pagano L. Giammarco S, et al. Expert Rev Hematol. 2017 Feb;10(2):147-154. doi: 10.1080/17474086.2017.1270754. Epub 2016 Dec 26. Expert Rev Hematol. 2017. PMID: 27967252 Review.
Areas covered: Risk factors include younger age, myelomonocytic or monocytic/monoblastic morphology, microgranular variant of acute promyelocitic leukemia and T-cell ALL, and some cytogenetic abnormalities. Poor prognosis due to high early death rate secondary to leukostasis …
Areas covered: Risk factors include younger age, myelomonocytic or monocytic/monoblastic morphology, microgranular variant of acute promyelo …
Hyperleukocytosis and leukostasis in acute and chronic leukemias.
Macaron W, Sargsyan Z, Short NJ. Macaron W, et al. Leuk Lymphoma. 2022 Aug;63(8):1780-1791. doi: 10.1080/10428194.2022.2056178. Epub 2022 Mar 31. Leuk Lymphoma. 2022. PMID: 35357988 Review.
Leukostasis is a life-threatening complication of high concentrations of circulating leukemic cells, most often myeloblasts. ...In this review, we discuss the pathophysiology, clinical manifestations, diagnosis, and management of leukemic hyperleukocytosis and leukostas …
Leukostasis is a life-threatening complication of high concentrations of circulating leukemic cells, most often myeloblasts. ...In th …
The Role of Inflammation in Diabetic Retinopathy.
Forrester JV, Kuffova L, Delibegovic M. Forrester JV, et al. Front Immunol. 2020 Nov 6;11:583687. doi: 10.3389/fimmu.2020.583687. eCollection 2020. Front Immunol. 2020. PMID: 33240272 Free PMC article. Review.
Hematology Emergencies in Adults With Critical Illness: Malignant Hematology.
Spring J, Munshi L. Spring J, et al. Chest. 2022 Jul;162(1):120-131. doi: 10.1016/j.chest.2022.02.004. Epub 2022 Feb 12. Chest. 2022. PMID: 35167862 Review.
This review highlights common causes of critical illness associated with hematologic malignancies, including the following: (1) neutropenic sepsis; (2) hyperleukocytosis and leukostasis across patients with acute myeloid leukemia; (3) complications of acute promyelocytic l …
This review highlights common causes of critical illness associated with hematologic malignancies, including the following: (1) neutropenic …
Hyperleukocytosis and Leukostasis in Acute Myeloid Leukemia: Can a Better Understanding of the Underlying Molecular Pathophysiology Lead to Novel Treatments?
Bewersdorf JP, Zeidan AM. Bewersdorf JP, et al. Cells. 2020 Oct 17;9(10):2310. doi: 10.3390/cells9102310. Cells. 2020. PMID: 33080779 Free PMC article. Review.
Hyperleukocytosis has been associated with an adverse prognosis and a higher incidence of life-threatening complications such as leukostasis, disseminated intravascular coagulation (DIC), and tumor lysis syndrome (TLS). ...However, the interactions between leukemic blasts …
Hyperleukocytosis has been associated with an adverse prognosis and a higher incidence of life-threatening complications such as leukosta …
The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.
Altmann C, Schmidt MHH. Altmann C, et al. Int J Mol Sci. 2018 Jan 1;19(1):110. doi: 10.3390/ijms19010110. Int J Mol Sci. 2018. PMID: 29301251 Free PMC article. Review.
The trigger for developing diabetic retinopathy is diabetes-induced hyperglycemia, accompanied by leukostasis and vascular leakages. Transcriptional changes in activated microglia, mediated via the nuclear factor kappa-light-chain-enhancer of activated B cells (NFkappaB) a …
The trigger for developing diabetic retinopathy is diabetes-induced hyperglycemia, accompanied by leukostasis and vascular leakages. …
Fenofibrate for Diabetic Retinopathy.
Stewart S, Lois N. Stewart S, et al. Asia Pac J Ophthalmol (Phila). 2018 Nov-Dec;7(6):422-426. doi: 10.22608/APO.2018288. Epub 2018 Jul 30. Asia Pac J Ophthalmol (Phila). 2018. PMID: 30058790 Review.
These findings are supported by results of experimental studies, which have demonstrated beneficial effects of fenofibrate ameliorating retinal vascular leakage and leukostasis, downregulating vascular endothelial growth factor, and reducing endothelial cell and pericyte l …
These findings are supported by results of experimental studies, which have demonstrated beneficial effects of fenofibrate ameliorating reti …
Effects of diabetes on the eye.
Lutty GA. Lutty GA. Invest Ophthalmol Vis Sci. 2013 Dec 13;54(14):ORSF81-7. doi: 10.1167/iovs.13-12979. Invest Ophthalmol Vis Sci. 2013. PMID: 24335073 Free PMC article. Review.
The initial events in animal models of DR are increased vascular permeability and leukostasis. This binding of leukocytes to the endothelium results from an increase in intracellular adhesion molecule-1 (ICAM-1) on the retinal capillary endothelium (EC) and expression of C …
The initial events in animal models of DR are increased vascular permeability and leukostasis. This binding of leukocytes to the endo …
The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S. Korkmaz S. Transfus Apher Sci. 2018 Feb;57(1):4-7. doi: 10.1016/j.transci.2018.02.006. Epub 2018 Feb 20. Transfus Apher Sci. 2018. PMID: 29477941 Review.
Although it can affect any organ system, symptoms usually arise from involvement of the cerebral, pulmonary and renal microvasculature. The term "leukostasis" refers to 'symptomatic hyperleukocytosis' which is a medical emergency that needs prompt recognition and initiatio …
Although it can affect any organ system, symptoms usually arise from involvement of the cerebral, pulmonary and renal microvasculature. The …
89 results